A headline is fueling concern about Johnson and Johnson's one-shot vaccine, and whether it's less effective against the Delta variant. But experts point out the new study, out of NYU's school of ...
U.S. health officials said Monday Johnson & Johnson’s COVID-19 vaccine may pose a "small possible risk" of a rare neurological disorder known as Guillain-Barré syndrome, another setback for the ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ROCHESTER, N.Y. (WROC) — More people are ...
WASHINGTON - On Tuesday, U.S. officials recommended a "pause" on the use of the Johnson & Johnson COVID-19 vaccine in order to investigate U.S. reports of a rare type of blood clot following ...
How do vaccines work? Here's what medical experts want you to know about safety and efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results